ArticleBMC cancer2014

Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.

Rosalba D'Alessandro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.